iX Biopharma Ltd. engages in the development and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. It operates through the following segments: Specialty Pharmaceutical, and Nutraceutical. The Specialty Pharmaceutical segment develops, manufactures and sells pharmaceutical and nutraceutical products. The Nutraceutical segment offers nutraceutical products. The company was founded by Lee Yip Hang on May 8, 2004 and is headquartered in Singapore.